Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| microglial cell | 5 studies | 21% ± 6% | |
| endothelial cell | 4 studies | 22% ± 6% | |
| adipocyte | 4 studies | 21% ± 2% | |
| fibroblast | 4 studies | 16% ± 1% | |
| astrocyte | 4 studies | 25% ± 3% | |
| oligodendrocyte precursor cell | 4 studies | 24% ± 5% | |
| mast cell | 4 studies | 20% ± 7% | |
| classical monocyte | 3 studies | 20% ± 5% | |
| myeloid cell | 3 studies | 16% ± 0% | |
| abnormal cell | 3 studies | 20% ± 2% |
Insufficient scRNA-seq data for expression of ARHGEF40 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adrenal gland | 100% | 17397.97 | 258 / 258 | 99% | 41.29 | 228 / 230 |
| thymus | 100% | 6523.33 | 653 / 653 | 98% | 44.35 | 595 / 605 |
| pancreas | 100% | 5173.77 | 327 / 328 | 98% | 38.16 | 174 / 178 |
| brain | 98% | 2896.07 | 2581 / 2642 | 100% | 57.47 | 703 / 705 |
| skin | 97% | 3263.56 | 1759 / 1809 | 100% | 69.92 | 470 / 472 |
| kidney | 100% | 3610.01 | 89 / 89 | 97% | 22.70 | 871 / 901 |
| liver | 98% | 5179.62 | 222 / 226 | 98% | 29.97 | 396 / 406 |
| breast | 100% | 7204.06 | 459 / 459 | 95% | 20.34 | 1061 / 1118 |
| stomach | 99% | 2829.53 | 357 / 359 | 95% | 18.89 | 271 / 286 |
| ovary | 100% | 7346.83 | 180 / 180 | 93% | 23.55 | 398 / 430 |
| intestine | 100% | 4647.72 | 965 / 966 | 92% | 19.60 | 487 / 527 |
| bladder | 100% | 5129.76 | 21 / 21 | 89% | 17.22 | 448 / 504 |
| lung | 100% | 5509.53 | 577 / 578 | 83% | 13.12 | 964 / 1155 |
| uterus | 100% | 7437.82 | 170 / 170 | 83% | 21.45 | 382 / 459 |
| prostate | 100% | 5122.68 | 244 / 245 | 82% | 10.14 | 410 / 502 |
| esophagus | 81% | 2876.79 | 1165 / 1445 | 79% | 13.02 | 144 / 183 |
| adipose | 100% | 7445.54 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 100% | 11676.18 | 241 / 241 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 4852.32 | 1332 / 1335 | 0% | 0 | 0 / 0 |
| heart | 98% | 3003.93 | 846 / 861 | 0% | 0 | 0 / 0 |
| muscle | 94% | 2120.78 | 757 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 75% | 9.15 | 60 / 80 |
| peripheral blood | 68% | 6468.96 | 633 / 929 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 60% | 8.22 | 27 / 45 |
| lymph node | 0% | 0 | 0 / 0 | 24% | 1.99 | 7 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0051056 | Biological process | regulation of small GTPase mediated signal transduction |
| GO_0007411 | Biological process | axon guidance |
| GO_0005829 | Cellular component | cytosol |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0019898 | Cellular component | extrinsic component of membrane |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005085 | Molecular function | guanyl-nucleotide exchange factor activity |
| Gene name | ARHGEF40 |
| Protein name | Rho guanine nucleotide exchange factor 40 (Protein SOLO) ARHGEF40 Rho guanine nucleotide exchange factor 40 |
| Synonyms | SOLO |
| Description | FUNCTION: May act as a guanine nucleotide exchange factor (GEF). . |
| Accessions | A0A2X0SFG4 ENST00000556399.5 G3V3N2 ENST00000553709.5 ENST00000298694.9 [Q8TER5-1] Q8TER5 G3V485 ENST00000555038.5 G3V5C1 |
